EMED — Electromedical Technologies Income Statement
0.000.00%
- $0.17m
- $2.44m
- $1.35m
Annual income statement for Electromedical Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.83 | 0.738 | 0.907 | 1.15 | 1.35 |
Cost of Revenue | |||||
Gross Profit | 0.591 | 0.544 | 0.708 | 0.889 | 1.05 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.5 | 3.9 | 4.66 | 3.83 | 3.41 |
Operating Profit | -1.67 | -3.17 | -3.75 | -2.68 | -2.06 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.74 | -3.87 | -8.48 | -3.47 | -2.64 |
Net Income After Taxes | -1.74 | -3.87 | -8.48 | -3.47 | -2.64 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.74 | -3.87 | -8.48 | -3.47 | -2.64 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.74 | -3.87 | -12.3 | -3.58 | -2.64 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.057 | -0.174 | -0.241 | -0.019 | -0.01 |
Dividends per Share |